Effects of GP IIb/IIIa receptor monoclonal antibody (7E3), heparin, and aspirin in an ex vivo canine arteriovenous shunt model of stent thrombosis

Circulation

Volumn 95, Issue 4, 1997, Pages 1015-1021

  Makkar, Raj R ^c   Litvack, Frank ^c   Eigler, Neal L ^c   Nakamura, Masato ^c   Ivey, Pamela A ^c   Forrester, James S ^c   Shah, Prediman K ^c   Jordan, Robert E ^a   Kaul, Sanjay ^b  

^a CENTOCOR INC   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c NONE

Author keywords

angioplasty; platelets; thrombosis

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; FIBRINOGEN RECEPTOR; HEPARIN;

ANIMAL MODEL; ARTERIOVENOUS SHUNT; ARTERY BLOOD FLOW; ARTICLE; BLEEDING TIME; BLOOD CLOTTING TIME; CONTROLLED STUDY; DOG; DRUG EFFECT; GENE EXPRESSION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; SHEAR RATE; STENT; THROMBOCYTE AGGREGATION INHIBITION; THROMBOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0031042120     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.95.4.1015     Document Type: Article

References (11)

1. Nath FC, Muller DW, Ellis SG, Rosenschein U, Chapekis A, Quain L, Zimmerman C, Topol EJ. Thrombosis of a flexible coil coronary stent: frequency, predictors and clinical outcome. J Am Coll Cardiol. 1993;21:622-627.
2. Liu MW, Voorhees WD III, Agrawal S, Dean LS, Roubin GS. Stratification of the risk of thrombosis after intracoronary stenting for threatened or acute closure complicating coronary balloon angioplasty: a Cook registry study. Am Heart J. 1995;130:8-13.
3. Savage MP, Fischman DL, Schatz RA, Teirstein PS, Leon MB, Baim D, Ellis SG, Topol EJ, Hirshfeld JW, Cleman MW, Buchbinder M, Bailey S, Heuser R, Walker CM, Goldberg S, for the Palmaz-Schatz Stent Study Group. Long-term angiographic and clinical outcome after implantation of a balloon-expandable stent in the native coronary circulation. J Am Coll Cardiol. 1994;24:1207-1212.
4. Haude M, Erbel R, Issa H, Straub U, Rupprecht HJ, Treese N, Meyer J. Subacute thrombotic complications after intracoronary implantation of Palmaz-Schatz stents. Am Heart J. 1993;126:15-22.
5. Roubin GS, Cannon AD, Agrawal SK, Macander PJ, Dean LS, Baxley WA, Breland J. Intracoronary stenting for acute and threatened closure complicating percutaneous transluminal coronary angioplasty. Circulation. 1992;85:916-927.
6. Haude M, Erbel R, Straub U, Dietz U, Meyer J. Short and long term results after intracoronary stenting in human coronary arteries: monocentre experience with the balloon-expandable Palmaz-Schatz stent. Br Heart J. 1991;66:337-345.
7. Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I, Detre K, Veltri L, Ricci D, Noboyushi M, Cleman M, Heuser R, Almond D, Teirstein PS, Fish RD, Colombo A, Brinker J, Mosis J, Shaknovich A, Hirshfeld J, Bailey S, Ellis R, Goldberg S. A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease. N EngI J Med. 1994;331:496-501.
8. Lincoff AM, Topol EJ, Chapekis AT, George BS, Candela RJ, Muller DWM, Zimmerman CA, Ellis SG. Intracoronary stenting compared with conventional therapy for abrupt vessel closure complicating coronary angioplasty: a matched case-control study. J Am Coll Cardiol. 1993;21:866-875.
9. Hearn JA, King SB III, Douglas JS Jr, Carlin SF, Lembo NJ, Ghazzal ZMB. Clinical and angiographie outcomes after coronary artery stenting for acute or threatened closure after percutaneous transluminal coronary angioplasty: initial results with a balloon-expandable, stainless steel design. Circulation. 1993;88:2086-2096.
10. Lefkovits J, Plow EF, Topol EJ. Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine. N EngI J Med. 1993;332:1553-1559.
11. 2 fragments of the antiplatelet GPIIb/IIIa antibody 7E3 on arterial eversion graft occlusion, platelet aggregation, and bleeding time in dogs. Arterioscler Thromb. 1994;14:367-374.